123 related articles for article (PubMed ID: 28539063)
1. A QSAR classification model for neuraminidase inhibitors of influenza A viruses (H1N1) based on weighted penalized support vector machine.
Algamal ZY; Qasim MK; Ali HTM
SAR QSAR Environ Res; 2017 May; 28(5):415-426. PubMed ID: 28539063
[TBL] [Abstract][Full Text] [Related]
2. A binary QSAR model for classifying neuraminidase inhibitors of influenza A viruses (H1N1) using the combined minimum redundancy maximum relevancy criterion with the sparse support vector machine.
Qasim MK; Algamal ZY; Ali HTM
SAR QSAR Environ Res; 2018 Jul; 29(7):517-527. PubMed ID: 30037283
[TBL] [Abstract][Full Text] [Related]
3. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
Mercader AG; Pomilio AB
Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898
[TBL] [Abstract][Full Text] [Related]
4. A robust quantitative structure-activity relationship modelling of influenza neuraminidase a/PR/8/34 (H1N1) inhibitors based on the rank-bridge estimator.
Al-Dabbagh ZT; Algamal ZY
SAR QSAR Environ Res; 2019 Jun; 30(6):417-428. PubMed ID: 31122071
[TBL] [Abstract][Full Text] [Related]
5. Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors.
Li Y; Kong Y; Zhang M; Yan A; Liu Z
Mol Inform; 2016 Apr; 35(3-4):116-24. PubMed ID: 27491921
[TBL] [Abstract][Full Text] [Related]
6. QSAR model for predicting neuraminidase inhibitors of influenza A viruses (H1N1) based on adaptive grasshopper optimization algorithm.
Algamal ZY; Qasim MK; Lee MH; Ali HTM
SAR QSAR Environ Res; 2020 Nov; 31(11):803-814. PubMed ID: 32938208
[TBL] [Abstract][Full Text] [Related]
7. A new adaptive L1-norm for optimal descriptor selection of high-dimensional QSAR classification model for anti-hepatitis C virus activity of thiourea derivatives.
Algamal ZY; Lee MH
SAR QSAR Environ Res; 2017 Jan; 28(1):75-90. PubMed ID: 28176549
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.
Lian W; Fang J; Li C; Pang X; Liu AL; Du GH
Mol Divers; 2016 May; 20(2):439-51. PubMed ID: 26689205
[TBL] [Abstract][Full Text] [Related]
9. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Gao L; Zu M; Wu S; Liu AL; Du GH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship model for classifying the diverse series of antifungal agents using ratio weighted penalized logistic regression.
Alharthi AM; Lee MH; Algamal ZY; Al-Fakih AM
SAR QSAR Environ Res; 2020 Aug; 31(8):571-583. PubMed ID: 32628042
[TBL] [Abstract][Full Text] [Related]
11. Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Y
J Mol Model; 2010 Dec; 16(12):1809-18. PubMed ID: 20213331
[TBL] [Abstract][Full Text] [Related]
12. Complexity in influenza virus targeted drug design: interaction with human sialidases.
Chavas LM; Kato R; Suzuki N; von Itzstein M; Mann MC; Thomson RJ; Dyason JC; McKimm-Breschkin J; Fusi P; Tringali C; Venerando B; Tettamanti G; Monti E; Wakatsuki S
J Med Chem; 2010 Apr; 53(7):2998-3002. PubMed ID: 20222714
[TBL] [Abstract][Full Text] [Related]
13. QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.
Lü WJ; Chen YL; Ma WP; Zhang XY; Luan F; Liu MC; Chen XG; Hu ZD
Eur J Med Chem; 2008 Mar; 43(3):569-76. PubMed ID: 18255197
[TBL] [Abstract][Full Text] [Related]
14. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
15. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
Du QS; Huang RB; Wei YT; Du LQ; Chou KC
J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
[TBL] [Abstract][Full Text] [Related]
16. High-dimensional QSAR modelling using penalized linear regression model with L1/2-norm.
Algamal ZY; Lee MH; Al-Fakih AM; Aziz M
SAR QSAR Environ Res; 2016 Sep; 27(9):703-19. PubMed ID: 27628959
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
19. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of NH
Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
